id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-1451-0002,FDA,FDA-1978-N-1451,Hematology and Pathology Devices Classification of Blood Cell Diluents,Rule,Final Rule,2012-07-27T04:00:00Z,2012,7,2012-07-27T04:00:00Z,1980-10-15T03:59:59Z,2012-07-27T12:32:37Z,,0,0,090000648059b43e
FDA-1978-N-1451-0003,FDA,FDA-1978-N-1451,"Accession No. 88-86-05, Box 11 Retired",Other,Retired (RET),2012-07-27T04:00:00Z,2012,7,2012-07-27T04:00:00Z,,2012-07-27T12:32:37Z,,0,0,090000648059b43f
FDA-1978-N-1451-0001,FDA,FDA-1978-N-1451,Medical Devices Classification of Blood Cell Diluents,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-06-22T04:00:00Z,2012,6,2012-06-22T04:00:00Z,1979-11-14T04:59:59Z,2012-06-22T20:29:14Z,,0,0,090000648059b43b